Echinacoside Reduces Intracellular C-di-GMP Levels and Potentiates Tobramycin Activity Against Pseudomonas Aeruginosa Biofilm Aggregates

Overview

Journal NPJ Biofilms Microbiomes

Date 2025 Mar 7

PMID 40055321

Authors

Yu-Ming Cai

Feng Hong

Amber De Craemer

Jacob George Malone

Aurelie Crabbe

Tom Coenye

Affiliations

Soon will be listed here.

Abstract

Cyclic diguanylate (c-di-GMP) is a central biofilm regulator in Pseudomonas aeruginosa, where increased intracellular levels promote biofilm formation and antibiotic tolerance. Targeting the c-di-GMP network may be a promising anti-biofilm approach, but most strategies studied so far aimed at eliminating surface-attached biofilms, while in vivo P. aeruginosa biofilms often occur as suspended aggregates. Here, the expression profile of c-di-GMP metabolism-related genes was analysed among 32 P. aeruginosa strains grown as aggregates in synthetic cystic fibrosis sputum. The diguanylate cyclase SiaD proved essential for auto-aggregation under in vivo-like conditions. Virtual screening predicted a high binding affinity of echinacoside towards the active site of SiaD. Echinacoside reduced c-di-GMP levels and aggregate sizes and potentiated tobramycin activity against aggregates in >80% of strains tested. This synergism was also observed in P. aeruginosa-infected 3-D alveolar epithelial cells and murine lungs, demonstrating echinacoside's potential as an adjunctive therapy for recalcitrant P. aeruginosa infections.

References

Marvig R, Sommer L, Molin S, Krogh Johansen H . Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet. 2014; 47(1):57-64. DOI: 10.1038/ng.3148. View

Mikkelsen H, McMullan R, Filloux A . The Pseudomonas aeruginosa reference strain PA14 displays increased virulence due to a mutation in ladS. PLoS One. 2012; 6(12):e29113. PMC: 3245244. DOI: 10.1371/journal.pone.0029113. View

Ruhluel D, Fisher L, Barton T, Leighton H, Kumar S, Amores Morillo P . Secondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments. ISME J. 2024; 18(1). PMC: 11102083. DOI: 10.1093/ismejo/wrae065. View

Hee C, Habazettl J, Schmutz C, Schirmer T, Jenal U, Grzesiek S . Intercepting second-messenger signaling by rationally designed peptides sequestering c-di-GMP. Proc Natl Acad Sci U S A. 2020; 117(29):17211-17220. PMC: 7382256. DOI: 10.1073/pnas.2001232117. View

Dreifus J, ONeal L, Jacobs H, Subramanian A, Howell P, Wozniak D . The Sia System and c-di-GMP Play a Crucial Role in Controlling Cell-Association of Psl in Planktonic P. aeruginosa. J Bacteriol. 2022; 204(12):e0033522. PMC: 9794950. DOI: 10.1128/jb.00335-22. View

Barraud N, Schleheck D, Klebensberger J, Webb J, Hassett D, Rice S . Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J Bacteriol. 2009; 191(23):7333-42. PMC: 2786556. DOI: 10.1128/JB.00975-09. View

Guan C, Huang Y, Zhou Y, Han Y, Liu S, Liu S . FlhF affects the subcellular clustering of WspR through HsbR in . Appl Environ Microbiol. 2023; 90(1):e0154823. PMC: 10807432. DOI: 10.1128/aem.01548-23. View

Verstraete L, Aizawa J, Govaerts M, De Vooght L, Lavigne R, Michiels J . Persistence Level Reflects Antibiotic Survival of Natural Pseudomonas aeruginosa Isolates in a Murine Lung Infection Model. Microbiol Spectr. 2023; 11(3):e0497022. PMC: 10269860. DOI: 10.1128/spectrum.04970-22. View

Navarro M, De N, Bae N, Wang Q, Sondermann H . Structural analysis of the GGDEF-EAL domain-containing c-di-GMP receptor FimX. Structure. 2009; 17(8):1104-16. PMC: 2747306. DOI: 10.1016/j.str.2009.06.010. View

10.

Secor P, Michaels L, Ratjen A, Jennings L, Singh P . Entropically driven aggregation of bacteria by host polymers promotes antibiotic tolerance in . Proc Natl Acad Sci U S A. 2018; 115(42):10780-10785. PMC: 6196481. DOI: 10.1073/pnas.1806005115. View

11.

Gupta K, Liao J, Petrova O, Cherny K, Sauer K . Elevated levels of the second messenger c-di-GMP contribute to antimicrobial resistance of Pseudomonas aeruginosa. Mol Microbiol. 2014; 92(3):488-506. PMC: 4029167. DOI: 10.1111/mmi.12587. View

12.

Basu Roy A, Petrova O, Sauer K . Extraction and Quantification of Cyclic Di-GMP from . Bio Protoc. 2014; 3(14). PMC: 4241849. DOI: 10.21769/bioprotoc.828. View

13.

Rao F, Qi Y, Chong H, Kotaka M, Li B, Li J . The functional role of a conserved loop in EAL domain-based cyclic di-GMP-specific phosphodiesterase. J Bacteriol. 2009; 191(15):4722-31. PMC: 2715702. DOI: 10.1128/JB.00327-09. View

14.

Basu Roy A, Sauer K . Diguanylate cyclase NicD-based signalling mechanism of nutrient-induced dispersion by Pseudomonas aeruginosa. Mol Microbiol. 2014; 94(4):771-93. PMC: 4227967. DOI: 10.1111/mmi.12802. View

15.

Facchini M, De Fino I, Riva C, Bragonzi A . Long term chronic Pseudomonas aeruginosa airway infection in mice. J Vis Exp. 2014; (85). PMC: 4151694. DOI: 10.3791/51019. View

16.

Qvortrup K, Hultqvist L, Nilsson M, Jakobsen T, Jansen C, Uhd J . Small Molecule Anti-biofilm Agents Developed on the Basis of Mechanistic Understanding of Biofilm Formation. Front Chem. 2019; 7:742. PMC: 6838868. DOI: 10.3389/fchem.2019.00742. View

17.

Chen G, Zhou J, Zuo Y, Huo W, Peng J, Li M . Structural basis for diguanylate cyclase activation by its binding partner in . Elife. 2021; 10. PMC: 8457831. DOI: 10.7554/eLife.67289. View

18.

Malone J . Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs. Infect Drug Resist. 2015; 8:237-47. PMC: 4524453. DOI: 10.2147/IDR.S68214. View

19.

Hengge R . High-specificity local and global c-di-GMP signaling. Trends Microbiol. 2021; 29(11):993-1003. DOI: 10.1016/j.tim.2021.02.003. View

20.

Rosay T, Bazire A, Diaz S, Clamens T, Blier A, Mijouin L . Pseudomonas aeruginosa Expresses a Functional Human Natriuretic Peptide Receptor Ortholog: Involvement in Biofilm Formation. mBio. 2015; 6(4). PMC: 4550695. DOI: 10.1128/mBio.01033-15. View